ロード中...
Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer
BACKGROUND: Pancreatic ductal adenocarcinoma is one of the leading causes of cancer-related death worldwide. Immune checkpoint blockade therapy, including anti-PD-1 and anti-PD-L1, is a new therapeutic strategy for cancer treatment but the monotherapy with PD-L1 inhibitors for pancreatic cancer is a...
保存先:
| 出版年: | J Exp Clin Cancer Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6359760/ https://ncbi.nlm.nih.gov/pubmed/30709380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1044-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|